Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies

2021 ◽  
Vol 106 ◽  
pp. 104489
Author(s):  
Faiza Saleem ◽  
Kanwal ◽  
Khalid Mohammed Khan ◽  
Sridevi Chigurupati ◽  
Mehwish Solangi ◽  
...  
2016 ◽  
Vol 121 ◽  
pp. 410-421 ◽  
Author(s):  
Alaa A.-M. Abdel-Aziz ◽  
Laila A. Abou-Zeid ◽  
Kamal Eldin H. ElTahir ◽  
Rezk R. Ayyad ◽  
Magda A.-A. El-Sayed ◽  
...  

Molecules ◽  
2017 ◽  
Vol 22 (6) ◽  
pp. 1005 ◽  
Author(s):  
Huey Kwong ◽  
Siau Mah ◽  
Tze Chia ◽  
Ching Quah ◽  
Gin Lim ◽  
...  

2015 ◽  
Vol 11 (5) ◽  
pp. 489-496
Author(s):  
Jamshed Iqbal ◽  
Mariya al-Rashida ◽  
Ayesha Babar ◽  
Abdul Hameed ◽  
Muhammad Khan ◽  
...  

Molecules ◽  
2015 ◽  
Vol 20 (5) ◽  
pp. 7454-7473 ◽  
Author(s):  
Fatma Turkmenoglu ◽  
İpek Baysal ◽  
Samiye Ciftci-Yabanoglu ◽  
Kemal Yelekci ◽  
Hamdi Temel ◽  
...  

2021 ◽  
Vol 10 (4) ◽  
pp. 443-458
Author(s):  
Rehab Fikry Taher ◽  
Ahmed A. Al-Karmalawy ◽  
Ahmed I. Abd El Maksoud ◽  
Hany Khalil ◽  
Amr Hassan ◽  
...  

Introduction: Hymenosporum flavum (Hook.) F. Muell. is the sole species within the genus Hymenosporum is known for its antimicrobial activity. The current study aims to examine the prospective activity of H. flavum as a safe supporter of sorafenib (as a reference standard) against hepatocellular carcinoma (HCC). Methods: Isolation and identification of compounds were made by chromatographic and spectroscopic methods. A fingerprint for the plant extract was done using HPLC-MS/MS spectrometric analysis. The total plant extract was examined in vitro for HCC activity. The isolated flavonoids were examined for their cytotoxic activities using molecular docking studies against both RAF-1 and ERK-2, and the promising compounds were further examined in vitro using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Results: Two new flavonols were isolated from the leaf extract of H. flavum (Hook.) F. Muell., quercetin-3-O-(glucopyranosyl 1→2 ribopyranoside) (1) and kaempferol-3-O-(glucopyranosyl 1→2 ribopyranoside) (2), accompanying other six known flavonoids (3-8), and identified via spectroscopic analysis. Moreover, HPLC- PDA/MS/MS spectrometric analysis revealed the presence of seventy phenolic metabolites. The cytotoxic activity of the plant extract confirmed its potential action on HepG2 cells indicated by the production level of lactate dehydrogenase (LDH) upon treatment compared with the normal cells. The isolated flavonoids were examined for their cytotoxic activity using molecular docking studies against both RAF-1 and ERK-2 as proposed mechanisms of their anticancer activities. Furthermore, compounds 1 and 3, which showed the best in silico results, were further examined in vitro using qRT-PCR. They exhibited promising inhibitory activities against both RAF-1 and ERK-2 gene expression. Moreover, they showed promising cytotoxic activities indicated by the MTT assay. Also, both of them improved the efficiency of sorafenib in targeting both RAF-1 and ERK-2 pathways suggesting synergistic combinations. Conclusion: Our findings showed the potential cytotoxic activity of H. flavum extract on HepG2 cells. Some isolated compounds (1 & 3) exhibited promising inhibitory activities against both RAF-1 and ERK-2 gene expression giving a lead future study for these compounds to be used in pharmaceutical preparations either alone or in combination with sorafenib.


Sign in / Sign up

Export Citation Format

Share Document